Results for tag: "Lung Infection Drug"

The Lung Infection Drug market is a subset of the larger Respiratory Drugs market. It includes drugs used to treat a variety of lung infections, such as pneumonia, bronchitis, and tuberculosis. These drugs are typically administered orally, intravenously, or through inhalation. They work by targeting the bacteria or virus causing the infection, reducing inflammation, and improving airway function. Common side effects of these drugs include nausea, vomiting, and diarrhea. The Lung Infection Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Pfizer, Merck, AstraZeneca, Sanofi, and Novartis. Show Less Read more